Skip to main content

Table 2 Association between the CEACAM1 serum expression levels and clinical parameters

From: Clinical and experimental studies regarding the expression and diagnostic value of carcinoembryonic antigen-related cell adhesion molecule 1 in non-small-cell lung cancer

Groups

No.

CEACAM1

  

Median (P50)

Range

P value

Age

    

<60

16

550.70

381.30 ~ 735.84

0.679

≥60

19

535.32

442.07 ~ 968.13

Sex

    

Male

16

588.98

442.07 ~ 968.13

0.042*

Female

19

513.95

381.30 ~ 735.84

Location

    

Left

11

519.89

381.30 ~ 674.69

0.619

Right

24

548.34

442.07 ~ 968.13

Staging**

    

Stage Ia ~ IIb

19

566.04

381.03 ~ 968.13

0.016*

Stage IIIa ~ IV

16

499.66

442.07 ~ 638.68

Grading

    

G1 ~ 2

14

542.42

442.07 ~ 968.13

0.775

G3 ~ 4

21

544.79

381.30 ~ 735.84

Histology

    

Squamous cell carcinoma

6

571.31

499.66 ~ 627.02

0.180

Adenocarcinoma

19

519.89

381.30 ~ 735.84

Others***

10

579.29

442.07 ~ 968.13

Lymph node metastasis

    

Node negative

13

566.04

381.30 ~ 968.13

0.274

Node positive

22

532.34

442.07 ~ 735.84

Invasion depth

    

pT1 ~ pT2

26

551.88

381.30 ~ 968.13

0.131

pT3 ~ pT4

9

519.89

442.07 ~ 638.68

  1. *P < 0.05.
  2. “**” 7th edition of the TNM classification of lung cancer by the International Association for the Study of Lung Cancer (IASLC).
  3. “***” Others represent 5 poorly differentiated carcinomas, 2 mixed histologies, 2 neuroendocrine carcinomas and 1 lymphoepithelioma-like carcinoma.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us